Biotechnology PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS October 12, 2020
Biotechnology GBT Receives Rare Impact Award for Innovation from the National Organization of Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) Tablets October 12, 2020
Biotechnology Immunomedics Announces FDA Orphan Drug Designation of Trodelvy(TM) for Adult and Pediatric Glioblastoma October 12, 2020
Biotechnology INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Investors are Encouraged to Contact the Firm – CBMG, PTI, VRTU, IMMU October 12, 2020
Biotechnology Amicus Therapeutics Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 49th Annual Meeting of the Child Neurology Society October 12, 2020
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMarin Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – BMRN October 10, 2020
Biotechnology FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder October 9, 2020
Search
Biotechnology
